These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6517881)

  • 1. In vivo significance of kinetic constants of protein proteinase inhibitors.
    Bieth JG
    Biochem Med; 1984 Dec; 32(3):387-97. PubMed ID: 6517881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucus proteinase inhibitor: a fast-acting inhibitor of leucocyte elastase.
    Boudier C; Bieth JG
    Biochim Biophys Acta; 1989 Mar; 995(1):36-41. PubMed ID: 2923915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor.
    Boudier C; Bieth JG
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):61-8. PubMed ID: 7945266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow tight binding inhibition of proteinase K by a proteinaceous inhibitor: conformational alterations responsible for conferring irreversibility to the enzyme-inhibitor complex.
    Pandhare J; Dash C; Rao M; Deshpande V
    J Biol Chem; 2003 Dec; 278(49):48735-44. PubMed ID: 14507912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theory and experimental method for determining individual kinetic constants of fast-acting, irreversible proteinase inhibitors.
    Leytus SP; Toledo DL; Mangel WF
    Biochim Biophys Acta; 1984 Jul; 788(1):74-86. PubMed ID: 6204689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo significance of kinetic constants of tight binding reversible proteinase inhibitors.
    Longstaff C
    Thromb Haemost; 1992 May; 67(5):533-6. PubMed ID: 1519212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methods of determination of equilibrium and kinetic parameters for the interaction of protein inhibitors with proteinases].
    Larionova NI; Kazanskaia NF; Iukubovskaia RI
    Biokhimiia; 1979 Jan; 44(1):3-17. PubMed ID: 420877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of chymotrypsin and human skin chymase: kinetics of time-dependent inhibition in the presence of substrate.
    Johnson LA; Moon KE; Eisenberg M
    Biochim Biophys Acta; 1988 Apr; 953(3):269-79. PubMed ID: 2451541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.
    Duranton J; Adam C; Bieth JG
    Biochemistry; 1998 Aug; 37(32):11239-45. PubMed ID: 9698370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of horse leucocyte proteinases by eglin, a proteinase inhibitor from leeches.
    Potempa J; Dubin A; Seemüller U; Schnebli HP; Koj A
    Biomed Biochim Acta; 1985; 44(2):335-9. PubMed ID: 4004837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human liver cathepsin L by alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine proteinase inhibitor from human serum.
    Pagano M; Esnard F; Engler R; Gauthier F
    Biochem J; 1984 May; 220(1):147-55. PubMed ID: 6547604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of inter-alpha-trypsin inhibitor.
    Pratt CW; Pizzo SV
    Biochemistry; 1987 May; 26(10):2855-63. PubMed ID: 2440471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of the hydrolysis of N-benzoyl-L-serine methyl ester catalysed by bromelain and by papain. Analysis of modifier mechanisms by lattice nomography, computational methods of parameter evaluation for substrate-activated catalyses and consequences of postulated non-productive binding in bromelain- and papain-catalysed hydrolyses.
    Wharton CW; Cornish-Bowden A; Brocklehurst K; Crook EM
    Biochem J; 1974 Aug; 141(2):365-381. PubMed ID: 4455211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between chymotrypsin and horse leucocyte neutral proteinases inhibitor.
    Dubin A; Hauck M
    Hoppe Seylers Z Physiol Chem; 1981 Oct; 362(10):1345-9. PubMed ID: 7308999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin.
    Faller B; Dirrig S; Rabaud M; Bieth JG
    Biochem J; 1990 Sep; 270(3):639-44. PubMed ID: 1700695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the interactions of human pancreatic elastase 2 with human alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin.
    Davril M; Laine A; Hayem A
    Biochem J; 1987 Aug; 245(3):699-704. PubMed ID: 3499146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary DNA cloning and kinetic characterization of a novel intracellular serine proteinase inhibitor: mechanism of action with trypsin and factor Xa as model proteinases.
    Morgenstern KA; Sprecher C; Holth L; Foster D; Grant FJ; Ching A; Kisiel W
    Biochemistry; 1994 Mar; 33(11):3432-41. PubMed ID: 8136380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-time analysis of the kinetics of irreversible enzyme inhibition by an unstable site-specific reagent.
    Topham CM
    Biochim Biophys Acta; 1988 Jun; 955(1):65-76. PubMed ID: 3382673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of a low molecular weight cysteine proteinase inhibitor from bovine muscle.
    Bige L; Ouali A; Valin C
    Biochim Biophys Acta; 1985 Dec; 843(3):269-75. PubMed ID: 3877527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.